Pharmacists and other employees did not question illicit drug prescriptions from “pill mills.” The Justice Department and the Drug Enforcement Administration (DEA) announced a settlement of $50 million…
Read MoreMedication
FDA Approves Drug for Narcolepsy
An official says this is the first drug that addresses the underlying biology of the disease. The Food and Drug Administration (FDA) has approved Orzeyful (oveporexton), a drug used to…
Read More
SAMHSA Awards Grant Funding to Treat Addiction and Mental Illness
The funding also helps to prevent overdoses and promote recovery. The Substance Abuse and Mental Health Services Administration (SAMHSA) announced $281 million in grant funding to support health…
Read MoreHHS and FDA Respond to DEA’s Action on Kratom-Related Products
3 synthetic compounds have been temporarily placed into Schedule I. The Departments of Health and Human Services (HHS) and Food and Drug Administration (FDA) commended the Drug Enforcement…
Read More
FDA Recalls Heart and Kidney Medications for Foreign Substances
Officials state the “probability of serious adverse health consequences is remote.” The U.S. Food and Drug Administration (FDA) announced the recall of almost a million bottles of heart…
Read More
President Announces Hundreds of Drug Additions to TrumpRx
More than 600 generic drugs have been added to TrumpRx, to help Americans find the best prices for their medications. President Donald Trump announced earlier this week that…
Read More
HHS Takes Action to Curb Psychiatric Overprescribing
Secretary Kennedy shared information and resources and advocated for a reduction in prescription medications for mental health. The Department for Health and Human Services (HHS) announced plans to…
Read More
DOJ and DEA Announce Marijuana Rescheduling Actions
Certain medical marijuana products moved to Schedule III as broader review begins. The Justice Department (DOJ) and Drug Enforcement Administration (DEA) announced that FDA-approved products containing marijuana—along with…
Read More
NIH Study Reveals Effectiveness of Coordinated Care
The trial in community health centers showed reduced blood pressure in clinics. A clinical trial funded by the National Institutes of Health (NIH) found that a team-based treatment…
Read More
President Trump Orders FDA to Expedite Psychedelic Drug Reviews
Ibogaine compounds have been studied as potential therapies for treating mental health. President Donald Trump ordered the Food and Drug Administration to expedite and prioritize reviews of research…
Read More